Table 5.
Association between adiponectin a and hypertension using crude and adjusted logistic regression among men and women (N = 3,663)
| Men (N = 1,334) | Women (N = 2,329) | |||
|---|---|---|---|---|
| Predictor | Odds ratio (95% confidence interval) | P -value | Odds ratio (95% confidence interval) | P -value |
| Adiponectin Q1b | 0.69 (0.49, 0.97) | .03 | 0.90 (0.70, 1.16) | .41 |
| Adiponectin Q2 | 0.70 (0.48, 1.00) | .05 | 0.90 (0.72, 1.13) | .36 |
| Adiponectin Q3 | 0.75 (0.51, 1.10) | .13 | 0.95 (0.76, 1.18) | .64 |
| Q4 | 1.0 | 1.0 | ||
| Adiponectin Q1c | 1.07 (0.73, 1.58) | .72 | 1.39 (1.05, 1.85) | .02 |
| Adiponectin Q2 | 0.94 (0.63, 1.41) | .76 | 1.32 (1.02, 1.70) | .04 |
| Adiponectin Q3 | 0.92 (0.60, 1.40) | .68 | 1.13 (0.88, 1.45) | .34 |
| Q4 | 1.0 | 1.0 | ||
| Adiponectin Q1d | 0.79 (0.49, 1.26) | .32 | 0.67 (0.46, 0.96) | .03 |
| Adiponectin Q2 | 0.75 (0.47, 1.20) | .23 | 0.86 (0.63, 1.16) | .32 |
| Adiponectin Q3 | 0.85 (0.53, 1.37) | .51 | 0.86 (0.65, 1.13) | .28 |
| Q4 | 1.0 | 1.0 | ||
| Adiponectin Q1e | 0.79 (0.49, 1.26) | .33 | 0.66 (0.46, 0.95) | .03 |
| Adiponectin Q2 | 0.75 (0.47, 1.19) | .22 | 0.85 (0.63, 1.16) | .33 |
| Adiponectin Q3 | 0.85 (0.53, 1.37) | .51 | 0.85 (0.64, 1.13) | .28 |
| Q4 | 1.0 | 1.0 | ||
| Adiponectin Q1f | 0.80 (0.50, 1.28) | .36 | 0.66 (0.46, 0.95) | .02 |
| Adiponectin Q2 | 0.75 (0.47, 1.20) | .23 | 0.86 (0.63, 1.16) | .32 |
| Adiponectin Q3 | 0.86 (0.53, 1.38) | .52 | 0.85 (0.64, 1.12) | .25 |
| Q4 | 1.0 | 1.0 | ||
aAdiponectin in quartiles (Q = quartile): 1) Q1 = ≤2.70 ug/mL, 2) Q2 = >2.70 – ≤4.2 ug/mL, 3)Q3 = >4.2 – ≤ 6.7 ug/mL, 4) Q4 > 6.7 ug/mL. The referent group is Q4 > 6.7 ug/mL.
b = Model 1, crude.
c = Model 2, partly adjusted for age.
d = Model 3, partly adjusted for age, fasting insulin, HOMA-IR(Insulin resistance), low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, total cholesterol, c-reactive protein, plasma leptin.
e = Model 4, partly adjusted for age, body mass index, smoking status, physical activity score, alcohol consumption status.
f = Model 5, fully adjusted for age, body mass index, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, total cholesterol, plasma leptin, fasting insulin, HOMA-IR, C-reactive protein, smoking status, physical activity score, alcohol consumption status, and socioeconomic status based on annual household income.
A two-tailed level of significance was established as P < .05.